A. Guminski, “Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study”, J of Skin, vol. 7, no. 2, p. s181, Mar. 2023.